CMS Reverses the Reimbursement for AVASTIN
November 17, 2009
In a move in response to the pressure of the AAO and several other ophthalmic groups, the CMS has rescinded Code Q2024 about reimbursement for Avastin. Reimbursement now reverts back to the original pre-October 1st policy of $50 per dose.
For more, see my writeup posted this morning on my online Journal.
Jump down to form below to submit your own comments